Showing 781-790 of 1097 results for "".
- Revealed: The Top Five Technology Trends Shaping the Beauty Industryhttps://modernaesthetics.com/news/revealed-the-top-five-technology-trends-shaping-the-beauty-industry-3/2473438/Generative AI technologies are increasingly transforming various industries, including beauty, according to a keynote presentation by Alice Chang, Founder and CEO of Perfect Corp at The Global Beauty and Fashion Tech Forum in New York City. “In today's fast-paced world, c
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- IL-17 Linked to Skin Aging: Studyhttps://modernaesthetics.com/news/il-17-linked-to-skin-aging-study/2473426/Interleukin (IL)-17 may plays a central role in skin aging, according to research from Institute for Research in Biomedicine (IRB Barcelona) in collaboration with the National Center for Genomic Analysis (CNAG). The study, which was led by Dr. Guiomar Solanas, Dr. Salvador Azn
- Eyebrow Thickness? It’s in Your Geneshttps://modernaesthetics.com/news/eyebrow-thickness-its-in-your-genes/2473425/The first gene mapping study on eyebrow thickness in Europeans discovered three previously unreported genetic loci, suggesting that eyebrow appearance has partly the same and partly different underlying genes in people from different parts of the world. The study, conducted by the Inter
- FDA Approves Galderma's Restylane Eyelighthttps://modernaesthetics.com/news/fda-approves-galdermas-restylane-eyelight/2473423/The U.S. Food and Drug Administration (FDA) approved Restylane Eyelight, a hyaluronic acid (HA) dermal filler for the correction of undereye hollowing, in adults over the age of 21. Restylane Eyelight is formulated with NASHA Technology, which has a firm gel te
- BTL Takes on Music Festival Season With Emfesthttps://modernaesthetics.com/news/btl-takes-on-music-festival-season-with-emfest/2473422/BTL’s Emfest is coming to set to the Pasea Resort and Spa in Huntington Beach, Calif. The event, slated for Aug. 26, 2023, will feature a diverse lineup of music performances. In addition to the musical aspect, Emfest will provide a wide range of wellness activities and
- Radiofrequency Microneedling: Optimize Your Resultshttps://modernaesthetics.com/news/radiofrequency-microneedling-optimize-your-results/2473417/For optimal results when treating patients with radiofrequency (RF) microneedling, anecdotal and personal experience guide Elizabeth L. Tanzi, MD, as there are “No significant comparison studies to date” on the
- Reveal Lasers Launches Eternahttps://modernaesthetics.com/news/reveal-lasers-launches-eterna-topic/2473419/Reveal Lasers LLC is launching Eterna, a radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables. "We are thrilled to introduce Eterna to the market," says Bob Daley, CEO of Reveal Lasers, in a
- Sentient Introduces Tixel in the UShttps://modernaesthetics.com/news/sentient-introduces-tixel-in-the-us/2473416/Sentient is rolling out Sentient Tixel in the US. Sentient Tixel uses thermal-mechanical action technology to resurface skin. Tixel technology uniquely combines heat with the forward motion of a medical-grade titanium tip without the use of lasers, radiation, ultrasound, or needles.
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo